Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures

J. Pfeilschifter, S. M. Seyedin, G. R. Mundy

Research output: Contribution to journalArticlepeer-review

226 Scopus citations


TGF-β1 is a polypeptide that is abundant in bone matrix, is produced by bone cells, and modulates proliferation and differentiated functions of osteoblastic cells in vitro. TGF-β2 is a closely related polypeptide that was originally isolated from bone matrix. TGF-β1 has been shown previously to stimulate prostaglandin production in cultures of neonatal mouse calvariae, which causes these bones to resorb. We found similar effects with TGF-β2. In comparison, TGF-β1 and TGF-β2 failed to stimulate bone resorption in fetal rat long bone cultures during a 3-d incubation period in concentrations up to 50-100 times greater than those capable of inducing bone resorption in calvariae. Incubation with TGF-β1 for a further 3 d decreased bone resorption up to 30%. Moreover, bone resorption induced by the bone-resorbing agents IL 1 and 1,25-dihydroxyvitamin D3 was partially or completely inhibited by TGF-β1 and TGF-β2 during the second half of the 6-d incubation period. Inhibition of DNA synthesis with hydroxyurea inhibited bone resorption in long bones in a similar pattern to that seen with TGF-β1. The inhibitory effects of TGF-β1 and TGF-β2 on bone resorption in long bone cultures may therefore be due to inhibition of osteoclast precursor proliferation.

Original languageEnglish (US)
Pages (from-to)680-685
Number of pages6
JournalJournal of Clinical Investigation
Issue number2
StatePublished - 1988

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures'. Together they form a unique fingerprint.

Cite this